Advisor Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3.26M Sell
38,956
-4,292
-10% -$327K 0.02% 581
2019
Q3
$2.93M Buy
43,248
+26,990
+166% +$1.78M 0.02% 614
2019
Q2
$1.08M Buy
16,258
+2,466
+18% +$144K 0.01% 1088
2019
Q1
$766K Sell
13,792
-20,670
-60% -$1.26M 0.01% 1280
2018
Q4
$1.71M Buy
34,462
+6,512
+23% +$398K 0.02% 698
2018
Q3
$2.41M Buy
27,950
+12,989
+87% +$926K 0.02% 573
2018
Q2
$868K Buy
14,961
+8,441
+129% +$412K 0.01% 944
2018
Q1
$263K Buy
6,520
+5,154
+377% +$195K ﹤0.01% 1780
2017
Q4
$47K Sell
1,366
-54
-4% -$1.79K ﹤0.01% 3133
2017
Q3
$47K Buy
1,420
+864
+155% +$28.3K ﹤0.01% 2992
2017
Q2
$19K Buy
556
+116
+26% +$3.38K ﹤0.01% 3534
2017
Q1
$11K Buy
440
+240
+120% +$4.99K ﹤0.01% 3739
2016
Q4
$3K Hold
200
﹤0.01% 4138
2016
Q3
$4K Hold
200
﹤0.01% 4007
2016
Q2
$3K Buy
+200
New +$2.33K ﹤0.01% 4001

Other funds holding TDOC

Advisor Group's TDOC Position: Q4 2019 in Review

Advisor Group reduced its Teladoc Health (TDOC) stake by 9.9% in Q4 2019, selling an estimated $327K and leaving 38,956 shares worth $3.26M. The position accounts for 0.02% of the portfolio, ranked #581.

Advisor Group first reported a position in TDOC in Q2 2016 and has held it in 15 quarters since. 420 funds tracked by Wall St. Rank hold TDOC as of Q4 2019.

  • Advisor Group held 38,956 shares of Teladoc Health worth $3.26M as of Q4 2019.
  • Advisor Group sold 4,292 Teladoc Health shares in Q4 2019, an estimated $327K.
  • Teladoc Health made up 0.02% of Advisor Group's portfolio in Q4 2019, its #581 holding.
  • Advisor Group first reported a position in Teladoc Health in Q2 2016 and has held it in 15 quarters since.
  • 420 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.